Cargando…

Comparison of olopatadine with ketotifen for allergic conjunctivitis: a meta-analysis study

INTRODUCTION: Allergic conjunctivitis is one of the most common non-traumatic extraocular inflammatory diseases. AIM: The comparison of olopatadine with ketotifen remains elusive for the treatment of allergic conjunctivitis, and this meta-analysis aims to explore the impact of olopatadine versus ket...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Shiyu, Zhong, Shenquan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2023
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258714/ https://www.ncbi.nlm.nih.gov/pubmed/37312902 http://dx.doi.org/10.5114/ada.2023.127647

Ejemplares similares

Topical Olopatadine Hydrochloride versus Ketotifen Fumarate for Allergic Conjunctivitis
por: Patel, Dharmistha, et al.
Publicado: (2018)

Treatment of allergic conjunctivitis with olopatadine hydrochloride eye drops
por: Uchio, Eiichi
Publicado: (2008)

The effect of ketotifen on inflammatory markers in allergic conjunctivitis: an open, uncontrolled study
por: Martín, Andrea P, et al.
Publicado: (2003)

Comparison of effects of alcaftadine and olopatadine on conjunctival epithelium and eosinophil recruitment in a murine model of allergic conjunctivitis
por: Ono, Santa J, et al.
Publicado: (2011)

The effectiveness of olopatadine hydrochloride eye drops for allergic conjunctivitis: Protocol for a systematic review
por: Zi, Yingxin, et al.
Publicado: (2020)

Pooled analysis of two studies evaluating efficacy and safety of olopatadine hydrochloride 0.77% in patients with allergic conjunctivitis
por: McLaurin, Eugene, et al.
Publicado: (2017)

Efficacy of 0.05% epinastine and 0.1% olopatadine for allergic conjunctivitis as seasonal and preseasonal treatment
por: Mizoguchi, Takanori, et al.
Publicado: (2017)

Efficacy and safety of olopatadine hydrochloride 0.77% in patients with allergic conjunctivitis using a conjunctival allergen-challenge model
por: Torkildsen, Gail, et al.
Publicado: (2015)

Olopatadine ophthalmic solution suppresses substance P release in the conjunctivitis models
por: Tamura, Tadafumi
Publicado: (2012)

Comparative analysis of safety and efficacy of Alcaftadine 0.25%, Olopatadine hydrochloride 0.2% and Bepotastine besilate 1.5% in allergic conjunctivitis
por: Ayyappanavar, Shruti, et al.
Publicado: (2021)

Efficacy of Olopatadine versus Epinastine for Treating Allergic Conjunctivitis Caused by Japanese Cedar Pollen: A Double-Blind Randomized Controlled Trial
por: Fukushima, Atsuki, et al.
Publicado: (2014)

Management of allergic conjunctivitis: an evaluation of the perceived comfort and therapeutic efficacy of olopatadine 0.2% and azelastine 0.05% from two prospective studies
por: Epstein, Arthur B, et al.
Publicado: (2009)

Ocular Itch Relief with Alcaftadine 0.25% Versus Olopatadine 0.2% in Allergic Conjunctivitis: Pooled Analysis of Two Multicenter Randomized Clinical Trials
por: McLaurin, Eugene B., et al.
Publicado: (2014)

Elevated levels of prostaglandin E(2) in the tears of patients with severe allergic conjunctivitis and primary cultured conjunctival cells are suppressed by ketotifen and dexamethasone
por: Yamanishi, Ryutaro, et al.
Publicado: (2021)

Olopatadine hydrochloride and rupatadine fumarate in seasonal allergic rhinitis: A comparative study of efficacy and safety
por: Maiti, Rituparna, et al.
Publicado: (2011)

Observer-masked trial comparing efficacy of topical olopatadine (0.1%), bepotastine (1.5%), and alcaftadine (0.25%) in mild to moderate allergic conjunctivitis
por: Dudeja, Lakshey, et al.
Publicado: (2019)

Evaluation of alcaftadine 0.25% ophthalmic solution in acute allergic conjunctivitis at 15 minutes and 16 hours after instillation versus placebo and olopatadine 0.1%
por: Greiner, Jack V, et al.
Publicado: (2011)

Efficacy of olopatadine hydrochloride 0.1%, emedastine difumarate 0.05%, and loteprednol etabonate 0.5% for Chinese children with seasonal allergic conjunctivitis: a randomized vehicle‐controlled study
por: Liu, Rui‐fen, et al.
Publicado: (2016)

Comparison of efficacy, safety, and cost-effectiveness of rupatadine and olopatadine in patients of allergic rhinitis: A prospective, randomized, double-blind, parallel group study
por: Dakhale, Ganesh, et al.
Publicado: (2016)

Comparison of Gabapentin and Ketotifen in Treatment of Uremic Pruritus in Hemodialysis Patients
por: Amirkhanlou, Saeid, et al.
Publicado: (2016)

OLOPATADINE IN CHRONIC IDIOPATHIC URTICARIA
por: Godse, Kiran V
Publicado: (2009)

Allergic conjunctivitis
por: Rathi, Varsha M, et al.
Publicado: (2017)

Efficacy and Toxicity Evaluation of Bepotastine Besilate 1.5% Preservative-Free Eye Drops Vs Olopatadine Hydrochloride 0.2% Bak-Preserved Eye Drops in Patients with Allergic Conjunctivitis
por: Marini, María Cecilia, et al.
Publicado: (2023)

Recognition of allergic conjunctivitis in patients with allergic rhinitis
por: Williams, Daniel C, et al.
Publicado: (2013)

Allergic conjunctivitis in Jos-Nigeria
por: Malu, Keziah N.
Publicado: (2014)

Allergic conjunctivitis in Asia
por: Thong, Bernard Yu-Hor
Publicado: (2017)

The Prevalence of Allergic Rhinitis toAmbrosia Elatior in OlteniaArea and the Association with Allergic Conjunctivitis or Asthma
por: FLORINCESCU-GHEORGHE, NA, et al.
Publicado: (2019)

Allergic Conjunctivitis in Patients with Respiratory Allergic Symptoms; a Retrospective Study in Greece
por: MICHAILOPOULOS, Pavlos, et al.
Publicado: (2017)

Topical cyclosporine versus allergen specific immunotherapy in perennial allergic conjunctivitis
por: Dogan, Ceylan Uslu, et al.
Publicado: (2022)

Current Knowledge in Allergic Conjunctivitis
por: Villegas, Beatriz Vidal, et al.
Publicado: (2021)

Therapeutic Targets in Allergic Conjunctivitis
por: Labib, Bisant A., et al.
Publicado: (2022)

Model for Studying Anti- Allergic Drugs for Allergic Conjunctivitis in Animals
por: Nakazawa, Yosuke, et al.
Publicado: (2017)

Spectrophotometric Estimation of Ketotifen Fumarate from Tablet Formulations
por: Singhvi, I., et al.
Publicado: (2009)

Allergic Conjunctivitis-induced Retinal Inflammation Promotes Myopia Progression
por: Wei, Chang-Ching, et al.
Publicado: (2018)

Corneal biomechanical changes in allergic conjunctivitis
por: Wang, Qian, et al.
Publicado: (2021)

Intestinal Anisakiasis Treated Successfully with Prednisolone and Olopatadine Hydrochloride
por: Toyoda, Hideki, et al.
Publicado: (2016)

A contemporary look at allergic conjunctivitis
por: Dupuis, Pascale, et al.
Publicado: (2020)

Effect of ketotifen fumarate on experimental autoimmune orchitis and torsion of the spermatic cord
por: Moreno, Diego, et al.
Publicado: (2019)

Relationship between allergic rhinitis and allergic conjunctivitis (allergic rhinoconjunctivitis) - review
por: Iordache, Andreea, et al.
Publicado: (2022)

359 Prevalence of Allergic Conjunctivitis in Childhood
por: Geraldini, Marcos, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_svuhj12kb8onsd4to9r5tcomas